Effects of Energy Drinks on Cardiovascular Endpoints
Public ClinicalTrials.gov record NCT07212803. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of Energy Drinks on Electrocardiographic Parameters: A Randomized, Double Blind, Controlled, Crossover, Proof-of-concept Study
Study identification
- NCT ID
- NCT07212803
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- University of the Pacific
- Other
- Enrollment
- 3 participants
Conditions and interventions
Conditions
Interventions
- Control Product + Caffeine + Taurine Dietary Supplement
- Control Product + Taurine Dietary Supplement
- Energy Drink A + Placebo Capsule Dietary Supplement
- Energy Drink B Dietary Supplement
- Lower Dose Energy Drink A Dietary Supplement
- Placebo Drink + Caffeine Capsule Dietary Supplement
- Placebo Drink + Moxifloxacin Capsule Drug
- Placebo Drink + Placebo Capsule Other
Dietary Supplement · Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 40 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2025
- Primary completion
- Feb 28, 2026
- Completion
- Aug 31, 2026
- Last update posted
- Nov 25, 2025
2025 – 2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of the Pacific | Stockton | California | 95211 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07212803, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 25, 2025 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07212803 live on ClinicalTrials.gov.